New York, USA, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Diffuse Large B-cell Lymphoma Market to Show Immense Growth by 2032, Predicts DelveInsight | Leading Players to Look Out -...
HSBC initiated coverage of 11 U.S. biopharmaceutical and healthcare stocks in a note to clients on Wednesday. Analysts assigned Actinium Pharmaceuticals Inc (NYSE:ATNM), Amgen...
Biogen Inc. BIIB said Wednesday it has appointed Dr. Jane Grogan as head of research, effective Oct. 2. Grogan was most recently chief scientific officer at Graphite Bio, a cell...
Biogen Inc. BIIB shares slipped in the extended session Thursday after the Food and Drug Administration granted a soon-to-be Novartis AG NVS spinoff approval for the first...
The United States Food and Drug Administration (FDA) approved Zurzuvae (zuranolone), the first oral medication indicated to treat postpartum depression in adults developed by...
By Bansari Mayur Kamdar and Johann M Cherian (Reuters) -The benchmark S&P 500 and the Dow climbed higher on Monday following a choppy week, with investors looking ahead to a...
Investing.com -- Here is your Pro Recap of 4 head-turning deal dispatches you may have missed last week: merger deals at Biogen/Reata Pharmaceuticals, Banc of California/PacWest,...
Biogen Inc. (Nasdaq: BIIB) announced the appointment of Jane Grogan, Ph.D., as Executive Vice President, Head of Research effective 2 October 2023. Dr. Grogan will be a member of...